Acrivon Therapeutics (ACRV) Earnings Date & Reports

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACRV is expected to report earnings to rise 68.33% to -100 cents per share on May 13

Acrivon Therapeutics ACRV Stock Earnings Reports

Q1'25

Est.

$-1.01

Q4'24

Beat

by $0.17

Q3'24

Beat

by $0.15

Q2'24

Beat

by $0.23

Q1'24

Beat

by $0.06

The last earnings report on March 27 showed earnings per share of -60 cents, beating the estimate of -76 cents. With 204.17K shares outstanding, the current market capitalization sits at 62.39M.

View a ticker or compare two or three

Compare

ACRV